PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26095167-9	2015	CONCLUSIONS: Considering the effectiveness and safety, simeprevir-based triple therapy will continue to be a useful treatment option in Japan for treatment-naive or prior relapse patients with a favorable IL28B genotype.	Simeprevir	55-65	interferon lambda 3	Homo sapiens	205-210